Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Evaxion Biotech
Biotech
2 pharmas turn Scrooge, returning biotechs' unwanted gifts
The hand-back marks today's second pharma walk-away after Boehringer Ingelheim turned down its chance to license Nxera's schizophrenia candidate.
Gabrielle Masson
Dec 19, 2025 10:44am
Prominent vaccine critic ousted from HHS—Chutes & Ladders
Oct 31, 2025 8:30am
Evaxion stock slips on phase 2 cancer vax data
Oct 17, 2025 2:07pm
Merck opts in on Evaxian's preclinical vaccine candidate
Sep 25, 2025 7:00am
Merck bags options on Evaxion's AI-designed vaccine candidates
Sep 26, 2024 7:30am
Biogen CMO Maha Radhakrishnan joins Sofinnova—Chutes & Ladders
Aug 9, 2024 8:30am
